{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T07:49:46Z","timestamp":1794210586861,"version":"4.8.0"},"reference-count":25,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2011,6,27]],"date-time":"2011-06-27T00:00:00Z","timestamp":1309132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Develop Med Child Neuro"],"published-print":{"date-parts":[[2011,9]]},"abstract":"<jats:p>\n                    <jats:bold>Aim\u2002<\/jats:bold>\n                    Motor deterioration is a key feature in metachromatic leukodystrophy (MLD). The lack of data about its natural course impedes evaluation of therapeutic interventions. This study aimed to provide data about motor decline in MLD.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Method\u2002<\/jats:bold>\n                    Fifty\u2010nine patients (27 males, 32 females) with MLD (21 with late\u2010infantile MLD and 38 with juvenile MLD) were recruited within a nationwide survey (the German LEUKONET). Median (range) age at onset was 17\u2003months (9\u201327) for the group with late\u2010infantile MLD and 6\u2003years 2\u2003months (2y 11mo\u201314y) for the group with juvenile MLD. Gross motor function was assessed using the Gross Motor Function Classification for MLD.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results\u2002<\/jats:bold>\n                    In late\u2010infantile MLD, all patients showed loss of all gross motor function until 3\u2003years 4\u2003months of age. Patients with juvenile MLD showed a more variable and significantly longer motor decline (\n                    <jats:italic>p<\/jats:italic>\n                    &lt;0.001). For a patient with the juvenile form showing first gait disturbances, the probability of remaining stable for more than 1\u2003year was 84%, and 51% for more than 2\u2003years. Having lost independent walking, subsequent motor decline was as steep as in the late\u2010infantile form (median 5mo, interquartile range 3\u201322).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Interpretation\u2002<\/jats:bold>\n                    The course of motor disease was more variable in juvenile MLD with respect to onset and dynamics. However, the motor decline after the loss of independent walking was similarly steep in both forms. These data can serve as a reference for clinical studies that are topics of current research and allow definition of inclusion\/exclusion criteria.\n                  <\/jats:p>","DOI":"10.1111\/j.1469-8749.2011.04028.x","type":"journal-article","created":{"date-parts":[[2011,6,30]],"date-time":"2011-06-30T08:27:36Z","timestamp":1309422456000},"page":"850-855","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["The natural course of gross motor deterioration in metachromatic leukodystrophy"],"prefix":"10.1111","volume":"53","author":[{"given":"CHRISTIANE","family":"KEHRER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GUNNAR","family":"BLUMENSTOCK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VOLKMAR","family":"GIESELMANN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"INGEBORG","family":"KR\u00c4GELOH\u2010MANN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ON BEHALF OF THE GERMAN LEUKONET","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,6,27]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2008.00648.x"},{"key":"e_1_2_9_3_2","first-page":"3695","volume-title":"The metabolic and molecular bases of inherited disease","author":"von Figura K","year":"2011"},{"key":"e_1_2_9_4_2","first-page":"2693","volume-title":"The metabolic and molecular bases of inherited disease","author":"Kolodny EH","year":"1995"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.275"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705970"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1253412"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-007-0540-z"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19970905)71:4<475::AID-AJMG20>3.0.CO;2-C"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004399900075"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2010.03821.x"},{"key":"e_1_2_9_12_2","first-page":"539","volume-title":"The metabolic and molecular basis of inherited disease","author":"Moser H","year":"1965"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.1997.tb07414.x"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.1985.tb03768.x"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199101033240104"},{"key":"e_1_2_9_16_2","volume-title":"Neurology of hereditary metabolic diseases of children","author":"Lyon G","year":"2006"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1159\/000112332"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.57.3.168"},{"key":"e_1_2_9_19_2","first-page":"134","volume-title":"Brain lipids and lipoproteins, and the leucodystrophies","author":"Hagberg B","year":"1963"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005685010766"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000234129.97727.4d"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.50.12.1710"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1995.00540280098023"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.4.662"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2008.01058.x"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.62"}],"container-title":["Developmental Medicine &amp; Child Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1469-8749.2011.04028.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1469-8749.2011.04028.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1469-8749.2011.04028.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T10:09:14Z","timestamp":1695031754000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1469-8749.2011.04028.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,27]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["10.1111\/j.1469-8749.2011.04028.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-8749.2011.04028.x","archive":["Portico"],"relation":{},"ISSN":["0012-1622","1469-8749"],"issn-type":[{"value":"0012-1622","type":"print"},{"value":"1469-8749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,27]]},"assertion":[{"value":"2011-06-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}